BCL2 and cancer: Among these, BH3 mimetics are small molecules developed to inhibit pro-survival proteins (BCL-2, BCL-xL, MCL-1), unleashing BAX/BAK to promote MOMP and apoptosis onset in otherwise aberrantly surviving cancer cells.